Vimarsana
Biggest News Aggregation in the World

Page 15 - Pharma Intelligence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Intelligence Today - Breaking & Trending Today

Investegate |Informa PLC Announcements | Informa PLC: Informa Share Buyback Programme - Vimarsana News

Investegate |Informa PLC Announcements | Informa PLC: Informa Share Buyback Programme

Investegate announcements from Informa PLC, Informa Share Buyback Programme

Investegate |Informa PLC Announcements | Informa PLC: Transaction in Own Shares - Vimarsana News

Investegate |Informa PLC Announcements | Informa PLC: Transaction in Own Shares

Investegate announcements from Informa PLC, Transaction in Own Shares

Congestive Heart Failure (Heart Failure) accounts for 12.5% share of global Cardiovascular clinical trial activity in 2021 - Vimarsana News

Congestive Heart Failure (Heart Failure) accounts for 12.5% share of global Cardiovascular clinical trial activity in 2021

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...

Coronary Artery Disease (CAD) (Ischemic Heart Disease) accounts for 12.2% share of global Cardiovascular clinical trial activity in 2021 - Vimarsana News

Coronary Artery Disease (CAD) (Ischemic Heart Disease) accounts for 12.2% share of global Cardiovascular clinical trial activity in 2021

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...

Japan accounts for 4.6% share of global clinical trial activity in 2021 - Vimarsana News

Japan accounts for 4.6% share of global clinical trial activity in 2021

Methodology: The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I...